Statistical and radiobiological analysis of the so-called thyroid stunning

S Walrand, M Hesse, F Jamar - EJNMMI research, 2015 - Springer
Background The origin of the reduction in thyroid uptake after a low activity iodine scan, so-
called stunning effect, is still controversial. Two explanations prevail: an individual cell …

Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)

M Dietlein, J Dressler, W Eschner… - Nuklearmedizin …, 2007 - thieme-connect.com
Version 3 of the procedure guideline for 131 I whole-body scintigraphy (WBS) is the
counterpart to the procedure guideline for radioiodine therapy (version 3) and specify the …

Initial Staging of Differentiated Thyroid Carcinoma: Continued Utility of Posttherapy 131I Whole-Body Scintigraphy1

KP Donahue, NP Shah, SL Lee, ME Oates - Radiology, 2008 - pubs.rsna.org
Purpose: To retrospectively compare pretherapy iodine 123 (123I) and posttherapy iodine
131 (131I) sodium iodide whole-body scintigraphy of patients with newly diagnosed …

Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients

C Canzi, F Zito, F Voltini, E Reschini… - Medical …, 2006 - Wiley Online Library
The aim of this study was to verify the capability of an MIRD formula‐based dosimetric
method to predict radioiodine kinetics (fraction of administered iodine transferred to the …

[HTML][HTML] Clinical significance of discordant findings between pre-therapy 123I and post-therapy 131I whole body scan in patients with thyroid cancer

PE Bravo, B Goudarzi, U Rana… - … journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Radioactive therapy with 131 I (RAI) is commonly used during the management of patients
with differentiated thyroid cancer (DTC). The aim of this study was to determine the clinical …

Pitfalls and limitations of radionuclide imaging in endocrinology

K Agrawal, AAH Esmail, G Gnanasegaran… - seminars in nuclear …, 2015 - Elsevier
Several different techniques, radiopharmaceuticals, and imaging modalities are commonly
used in nuclear medicine for studies of endocrine organs. Nuclear medicine is used in the …

Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake

US Kristoffersen, B Hesse… - Clinical physiology …, 2006 - Wiley Online Library
Purpose: To evaluate the importance of 24 h radioiodine uptake (24 h RIU) for the outcome
of radioiodine treatment of hyperthyroidism. Methods: Retrospective analysis of 72 patients …

Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans

JB Cohen, JE Kalinyak… - Nuclear medicine …, 2004 - journals.lww.com
Background 123 I has been promoted for diagnostic imaging as a means of avoiding
'stunning'. It has also been suggested that the more favourable physical characteristics and …

[HTML][HTML] Nuclear molecular and theranostic imaging for differentiated thyroid cancer

A Sheikh, B Polack, Y Rodriguez… - Molecular imaging and …, 2017 - ncbi.nlm.nih.gov
Traditional nuclear medicine is rapidly being transformed by the evolving concepts in
molecular imaging and theranostics. The utility of new approaches in differentiated thyroid …

Usefulness of 99mTc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated …

M Chantadisai, K Kingpetch - Annals of nuclear medicine, 2014 - Springer
Objective The aim of the study was to evaluate the usefulness of 99m Tc-pertechnetate
whole body scan (WBS) with neck and chest SPECT/CT for detection of post-surgical thyroid …